Summary
TreatER - Clinical study in Parkinson’s disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug deliveryMore than 10 million people worldwide suffer from Parkinson’s...
More information & hyperlinks
Web resources: | https://treater.eu/ |